Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a

The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, ran...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Lababidi, Rania M., Mooty, Mohamad, Bonilla, Maria-Fernanda, Salem, Nouran M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242210/
https://www.ncbi.nlm.nih.gov/pubmed/32483527
http://dx.doi.org/10.1016/j.idcr.2020.e00837
Descripción
Sumario:The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.

Ejemplares similares